< Back to situation

[REVISION HISTORY]

Iran influenza vaccine shortage and rising respiratory cases

Updated 2 times since CLSTR started tracking revisions of this situation.

What changed

2026-09-20 20:03 UTC → 2026-09-29 07:24 UTC · added removed

Iran influenza vaccine shortage and rising respiratory health cases

Iran is experiencing challenges regarding influenza vaccine availability and the management of respiratory diseases. In late August, reports indicated a significant delay in the distribution of influenza vaccines, missing the typical late August to early October vaccination window. The shortage is attributed to a lack of domestic production and difficulties securing imports from European suppliers due to economic and logistical hurdles, such as international banking transfer issues. hurdles. While a shipment of 400,000 doses from China’s Sinopharm was expected, distribution was not anticipated until October. By mid-September, late September, health officials reported a significant rise in respiratory infections. Dr. Qobad Moradi, head of the Center for Communicable Disease Management, warned of a rise in both COVID-19 and influenza cases over a three-week period. He noted that the onset of the cold season and increased time spent in enclosed spaces are expected to would likely drive respiratory infections and potential influenza waves in the coming months. Addressing waves. Regarding school reopenings, Moradi stated advised that while the return of students increases student returns increase transmission risks, it they should not necessitate school closures. He emphasized three prevention measures for educational settings: ensuring closures if proper ventilation, teaching respiratory etiquette and hand hygiene, hygiene etiquette, and keeping sick children at home. While noting sick-child isolation are maintained. Recent data from the 27th week of the year shows that vaccines provide 40 COVID-19 positivity rates have nearly doubled, rising from 8.9 percent to 60 17.4 percent, surpassing high-alert thresholds. Influenza positivity has also increased to 1.7 percent, with Type B being the dominant strain, accounting for 80.7 percent prevention, officials continue of cases. Notably, children make up 36.5 percent of influenza infections, particularly in the 2 to recommend vaccination—particularly 15 age range. Pediatric specialist Mohammad Rahim Kadivar noted that COVID-19 circulation is currently outpacing influenza. While current variants may present less severe symptoms, authorities emphasize that the virus remains highly transmissible, especially for the elderly and those with underlying conditions—alongside mask-wearing in crowded areas for high-risk groups. conditions.

Versions

  1. 2026-09-29 07:24 UTC Iran influenza vaccine shortage and rising respiratory cases
  2. 2026-09-20 20:03 UTC Iran influenza vaccine shortage and respiratory health
  3. 2026-09-20 06:54 UTC Iran influenza vaccine shortage and respiratory health

Only revisions since CLSTR began indexing content versions appear here. Select a version to see what changed compared to the one before it.